Asset Details
Do you wish to reserve the book?
Early treatment interruption and nutritional status as predictors of mortality in Mycobacterium avium complex pulmonary disease
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Early treatment interruption and nutritional status as predictors of mortality in Mycobacterium avium complex pulmonary disease
Do you wish to request the book?
Early treatment interruption and nutritional status as predictors of mortality in Mycobacterium avium complex pulmonary disease
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Early treatment interruption and nutritional status as predictors of mortality in Mycobacterium avium complex pulmonary disease
2026
Overview
Mycobacterium avium complex pulmonary disease (MAC-PD) requires prolonged multidrug therapy. However, treatment outcomes remain suboptimal due to limited antibiotic efficacy, disease chronicity, and frequent early treatment interruption (ETI). Despite its clinical significance, data on the prevalence, risk factors, and long-term outcomes of ETI remain limited. Therefore, this study aims to identify factors associated with ETI and its impact on mortality. A retrospective cohort study of 420 patients treated with MAC-PD was conducted between 2010 and 2023. Patients were categorized into ETI (treatment duration < 12 months) and standard groups (treatment duration ≥ 12 months). Logistic regression was used to identify risk factors for ETI, whereas multivariate Cox proportional hazards regression was employed to evaluate factors associated with mortality. ETI occurred in 30% of patients. Low prognostic nutritional index (PNI) (adjusted odds ratio [aOR]: 0.92; 95% confidence Interval [CI]: 0.87-0.99) and grade 2 or higher adverse drug reactions (ADRs) (aOR: 5.65; 95% CI: 2.45-15.00) increased the risk of ETI. ETI was associated with higher mortality (adjusted hazard ratio: 2.86; 95% CI: 1.51-5.40). Additionally, low PNI scores indicated increased mortality risk. ETI is prevalent in MAC-PD and is strongly associated with ADRs and poor nutrition, both of which also predict higher long-term mortality. Early ADR monitoring and nutritional support are essential for improving treatment adherence and patient outcomes.
Publisher
Public Library of Science,PLOS,Public Library of Science (PLoS)
Subject
/ Anti-Bacterial Agents - administration & dosage
/ Anti-Bacterial Agents - adverse effects
/ Anti-Bacterial Agents - therapeutic use
/ Disease
/ Female
/ Humans
/ Lung Diseases - drug therapy
/ Lung Diseases - microbiology
/ Male
/ Medicine and Health Sciences
/ Mycobacterium avium Complex - drug effects
/ Mycobacterium avium-intracellulare Infection - drug therapy
/ Mycobacterium avium-intracellulare Infection - mortality
/ Patients
/ Proteins
/ Success
